SELLAS Life Sciences Group, Inc. (SLS)
7.08
-0.34
(-4.58%)
USD |
NASDAQ |
May 15, 16:00
7.13
+0.05
(+0.71%)
After-Hours: 20:00
SELLAS Life Sciences Group Total Liabilities (Quarterly) : 6.765M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Rezolute, Inc. | 8.625M |
| Krystal Biotech, Inc. | 120.24M |
| Spero Therapeutics, Inc. | 6.087M |
| Recursion Pharmaceuticals, Inc. | 314.75M |
| Whitehawk Therapeutics, Inc. | 11.06M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 114.18M |
| Shareholders Equity (Quarterly) | 107.41M |
| Debt to Equity Ratio | 0.0081 |
| Current Ratio | 17.22 |
| Net Debt Paydown Yield | 0.00% |